1. Home
  2. SKYT vs LRMR Comparison

SKYT vs LRMR Comparison

Compare SKYT & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYT
  • LRMR
  • Stock Information
  • Founded
  • SKYT 1991
  • LRMR N/A
  • Country
  • SKYT United States
  • LRMR United States
  • Employees
  • SKYT N/A
  • LRMR N/A
  • Industry
  • SKYT Semiconductors
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYT Technology
  • LRMR Health Care
  • Exchange
  • SKYT Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • SKYT 462.3M
  • LRMR 426.9M
  • IPO Year
  • SKYT 2021
  • LRMR N/A
  • Fundamental
  • Price
  • SKYT $9.69
  • LRMR $3.19
  • Analyst Decision
  • SKYT Strong Buy
  • LRMR Strong Buy
  • Analyst Count
  • SKYT 4
  • LRMR 9
  • Target Price
  • SKYT $12.75
  • LRMR $19.44
  • AVG Volume (30 Days)
  • SKYT 577.0K
  • LRMR 639.4K
  • Earning Date
  • SKYT 02-26-2025
  • LRMR 03-13-2025
  • Dividend Yield
  • SKYT N/A
  • LRMR N/A
  • EPS Growth
  • SKYT N/A
  • LRMR N/A
  • EPS
  • SKYT N/A
  • LRMR N/A
  • Revenue
  • SKYT $345,935,000.00
  • LRMR N/A
  • Revenue This Year
  • SKYT $21.36
  • LRMR N/A
  • Revenue Next Year
  • SKYT N/A
  • LRMR N/A
  • P/E Ratio
  • SKYT N/A
  • LRMR N/A
  • Revenue Growth
  • SKYT 26.89
  • LRMR N/A
  • 52 Week Low
  • SKYT $5.63
  • LRMR $3.01
  • 52 Week High
  • SKYT $19.00
  • LRMR $12.91
  • Technical
  • Relative Strength Index (RSI)
  • SKYT 50.02
  • LRMR 37.56
  • Support Level
  • SKYT $10.20
  • LRMR $3.06
  • Resistance Level
  • SKYT $10.97
  • LRMR $3.52
  • Average True Range (ATR)
  • SKYT 0.49
  • LRMR 0.22
  • MACD
  • SKYT 0.14
  • LRMR 0.02
  • Stochastic Oscillator
  • SKYT 72.93
  • LRMR 15.66

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: